logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
P

Pier Luigi Zinzani

institute of hematology l and a seragnoli

117H-index
1.8KPaper Count
6.1WCitation Count
Published Papers 356
Publication Date
logo
Correction to: Modern and multidisciplinary care in polycythemia vera
errAnnals of Hematology
IF2.4
err2026-07-25
err0
errOAAI
errFrancesca Palandri; Chiara Sartor; Alessandro Pileri; Olga Addimanda; Christian Gagliardi; Michelangelo Sartori; Monica Benni; Maddalena Giannella; Federica Lo Dato; Elena Sabattini; Lorenzo Fiorino; Alessandra Dedola; Filippo Branzanti; Maria B. Rondinelli; Massimo Reta; Nazzareno Galiè; Pierluigi Viale; Benilde Cosmi; Michelangelo La Placa; Maria C. Morelli; Pier Luigi Zinzani
errShare
errSave
Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial
errHemaSphere
IF14.6
err2026-07-09
err0
errOAAI
errLuca De Carolis; Monia Capponi; Alessandro Mancini; Flavio Falcinelli; Caterina Stelitano; Alessandro Pulsoni; Edoardo Simonetti; Alessandra Romano; Gianna Maria D'Elia; Jacopo Olivieri; Maria Paola Martelli; Alessandra Pucciarini; Alessia Santi; Marta Naccari; Alessandra Venanzi; Antonio Bennati; Pier Luigi Zinzani; Marzia Varettoni; Simone Ferrero; Massimo Pini; Robin Foà; Elisa Lucchini; Maurizio Frezzato; Brunangelo Falini; Enrico Tiacci
errShare
errSave
Fixed-duration pirtobrutinib plus venetoclax–rituximab versus venetoclax–rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial
errThe Lancet
IF88.5
err2026-07-09
err0
errOAAI
errMatthew S Davids; Toby A Eyre; Jennifer A Woyach; Lindsey E Roeker; Alessandra Ferrajoli; Yucai Wang; Constantine S Tam; Wojciech Jurczak; Pier Luigi Zinzani; Martin Šimkovič; Jian-Yong Li; Francesc Bosch; Damien Roos-Weil; Paula Cramer; Anders Osterborg; Prioty Islam; Ryan Jacobs; Alan Skarbnik; Seema A Bhat; Suhyun Kang
errShare
errSave
First-line ibrutinib plus venetoclax for non-blastoid mantle cell lymphoma in patients ≥65 years or with TP53 mutations
errBlood
IF23.1
err2026-07-03
err0
errOAAI
errMichael Wang; Marc Hoffmann; Tomasz Wrobel; Marek Trneny; David Belada; Fatih Demirkan; Panayiotis Panayiotidis; Wojciech Jurczak; Pier Luigi Zinzani; Mary-Margaret Keating; Sung-Soo Yoon; Miklós Egyed; Constantine S. Tam; Nathalie A. Johnson; Edith Szafer-Glusman; Jennifer Lin; James P. Dean; Jutta K. Neuenburg; Gottfried von Keudell
errShare
errSave
The prognostic role of interim [18F]FDG PET/CT in Diffuse Large B cell lymphoma: an updated systematic review and meta-analysis
errClinical Lymphoma Myeloma and Leukemia
IF2.7
err2026-06-15
err0
errOAAI
errDomenico Albano; Stephane Chauvie; Alessio Rizzo; Francesco Bertagna; Beatrice Casadei; Umberto Vitolo; Alessandra Tucci; Pier Luigi Zinzani; Luca Guerra
errShare
errSave
Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study
errHemaSphere
IF14.6
err2026-05-21
err0
errOAAI
errNicola Polverelli; Annalisa Chiappella; Cristiana Carniti; Pierluigi Zinzani; Maurizio Musso; Maria Chiara Tisi; Fabio Ciceri; Ilaria Cutini; Armando Santoro; Patrizia Chiusolo; Anna Maria Barbui; Mirko Farina; Livia Donzelli; Lucia Brunello; Massimo Martino; Mauro Krampera; Alessia Castellino; Giovanni Grillo; Barbara Botto; Jacopo Olivieri; Michele Clerico; Pellegrino Musto; Attilio Olivieri; Antonio Bianchessi; Irene Defrancesco; Giulia Losi; Caterina Zerbi; Gianluca Martini; Elisa Roncoroni; Manuel Gotti; Maria Grazia Benevento; Alessia Taurino; Anna Fedina; Paolo Corradini; Luca Arcaini
errShare
errSave
Frontline nilotinib vs dasatinib in NEwly diagnosed chronic phase chronic myeloid leukemia: a propensity score analysis based on AIFA monitoring registries
errClinical Lymphoma Myeloma and Leukemia
IF2.7
err2026-04-24
err0
PREAI
errMassimo Breccia; Simone Celant; Fabrizio Pane; Alessandra Iurlo; Valentina Summa; Paolo Corradini; Pierluigi Zinzani; Pier Paolo Olimpieri
errShare
errSave
Modern and multidisciplinary care in polycythemia vera
errAnnals of Hematology
IF2.4
err2026-04-18
err0
errOAAI
errFrancesca Palandri; Chiara Sartor; Alessandro Pileri; Olga Addimanda; Christian Gagliardi; Michelangelo Sartori; Monica Benni; Maddalena Giannella; Federica Lo Dato; Elena Sabattini; Lorenzo Fiorino; Alessandra Dedola; Filippo Branzanti; Maria B. Rondinelli; Massimo Reta; Nazzareno Galiè; Pierluigi Viale; Benilde Cosmi; Michelangelo La Placa; Maria C. Morelli; Pier Luigi Zinzani
errShare
errSave
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up
errBlood Advances
IF7.1
err2026-04-17
err0
errOAAI
errRoger G. Owen; Helen McCarthy; Shirley D’Sa; Sheeba K. Thomas; Olivier Tournilhac; Francesco Forconi; Marie José Kersten; Pier Luigi Zinzani; Sunil Iyengar; Jaimal Kothari; Monique C. Minnema; Efstathios Kastritis; Bruce D. Cheson; Harriet S. Walter; Daniel Greenwald; Roser Calvo; Yi Li; Simon Rule; Richard R. Furman
errShare
errSave
A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma
errAmerican Journal of Hematology
IF9.9
err2026-04-10
err0
PREAI
errGabriele Gugliotta; Lisa Argnani; Martina Cantelli; Antonio Pinto; Ausilia Gorgone; Francesco Piazza; Claudio Fozza; Vincenza Fernanda Fesce; Fabrizio Marino; Melania Celli; Elsa Pennese; Francesco Gaudio; Pietro Lauzzana; Luca Pezzullo; Sonya De Lorenzo; Paulina Maria Nierychlewska; Giusy Ceparano; Fabrizio Pane; Beatrice Casadei; Cinzia Pellegrini; Claudia Romano; Pier Luigi Zinzani
errShare
errSave
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
errBlood Cancer Journal
IF11.6
err2026-01-28
err0
errOAAI
errEva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage
errShare
errSave
Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc Analysis of Italian Real-World Data from the PRO-MIND Study
errDiseases 2025, Vol. 13, Page 399
IF3
err2025-12-15
err0
errOAAI
errPier Luigi Zinzani; Nicola Battaglia; Mario Lapecorella; Guido Gini; Maria Cristina Cox; Stefan Hohaus; Antonio Pinto
errShare
errSave
Polatuzumab Vedotin and Glofitamab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the Compassionate Use Program in Italy
errHEMATOLOGICAL ONCOLOGY
IF3.9
err2025-12-14
err0
errOAAI
errZinzani, Pier Luigi; Dell'Omo, Giulia; Fusco, Letizia; Peduto, Ilaria; Galeone, Carlotta; Cavallo, Federica; Gritti, Giuseppe
errShare
errSave
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma
errFuture Oncology
IF2.6
err2025-12-10
err0
errOAAI
errNathalie A. Johnson; Pier Luigi Zinzani; Eva Domingo-Domenech; Joshua Brody; Justin Kline; Bijal Dinesh Shah; Amitkumar Nitinkumar Mehta; Herve Ghesquieres; Kerry J. Savage; Paul M. Barr; Armando Santoro; Silvia Ferrari; David Cunningham; Graham P. Collins; Michelle Fanale; Jennifer Krajewski; Alev Akyol; Russell Crowe; Rachael Wen; John Kuruvilla
errShare
errSave
Early time-to-relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium
errBlood
IF23.1
err2025-12-08
err0
errOAAI
errMark N Sorial; Luis E Malpica Castillo; Carlos Chiattone; Edith Julia; Emmanuel Bachy; Stefan K Barta; Robert Stuver; Eric Jacobsen; Massimo Federico; Hasmukh Jain; Henry Miles Prince; Francine Foss; Pier Luigi Zinzani; Takeshi Okatani; Won-Seog Kim; Estelle Verburgh; Mubarak Al-Mansour; Maria Elena Cabrera; Govind Bhagat; Changyu Shen
errShare
errSave
Lessons learned from experience of phosphatidylinositol 3-kinase inhibitors in chronic lymphocytic leukemia and lymphoma
errHAEMATOLOGICA
IF7.9
err2025-12-01
err0
errOAAI
errGhione, Paola; Zinzani, Pier Luigi; Brown, Jennifer R.
errShare
errSave
Defining and Addressing the Current Unmet Medical Needs for the Frontline Treatment of Advanced Stage Aggressive Large B-Cell Lymphoma: A Perspective From an Ad Hoc Panel of Italian Experts
errHematological Oncology
IF3.9
err2025-11-03
err0
errOAAI
errAntonio Pinto; Carmelo Carlo-Stella; Monia Marchetti; Caterina Patti; Annalisa Arcari; Nicola Di Renzo; Marco Laddetto; Maurizio Martelli; Pier Luigi Zinzani
errShare
errSave
CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE study
errHAEMATOLOGICA
IF7.9
err2025-11-01
err1
errOAAI
errMagni, Martina; Jonnalagadda, Sadhana; Bonifazi, Francesca; Bonafe, Massimiliano; Ljevar, Silva; Zanirato, Giada; De Matteis, Serena; Stella, Federico; Barone, Angelica; Bertolini, Giulia; Bermema, Anisa; Chiappella, Annalisa; Tisi, Maria Chiara; Cutini, Ilaria; Novo, Mattia; Grillo, Giovanni; Farina, Mirko; Martino, Massimo; Krampera, Mauro; Massaia, Massimo; Arcaini, Luca; Bramanti, Stefania; Zinzani, Pier Luigi; Dodero, Anna; Corradini, Paolo; Carniti, Cristiana
errShare
errSave
A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection
errHematological Oncology
IF3.9
err2025-09-23
err0
errOAAI
errMonia Marchetti; Paolo Corradini; Luca Arcaini; Stefania Bramanti; Alice Di Rocco; Marco Ladetto; Stefano Luminari; Luigi Rigacci; Pier Luigi Zinzani
errShare
errSave
Treatment persistence and overall survival in myelofibrosis treated with ruxolitinib were not affected by the covid-19 pandemic, despite the reduced starting dose: Analysis of AIFA registries
errAnnals of Hematology
IF2.4
err2025-09-20
err0
errOAAI
errMassimo Breccia; Simone Celant; Francesca Palandri; Francesco Passamonti; Pier Paolo Olimpieri; Valentina Summa; Annalisa Guarcello; Giuseppe Alberto Palumbo; Fabrizio Pane; Paola Guglielmelli; Pierluigi Zinzani; Paolo Corradini; Pierluigi Russo
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Elı́as Campo
H-index: 173 · Papers: 1.6K
D
David Cunningham
H-index: 153 · Papers: 2.1K
O
Olivier Hermine
H-index: 135 · Papers: 1.8K
M
Martin S. Tallman
H-index: 134 · Papers: 1.3K
G
Gilles Salles
H-index: 129 · Papers: 1.7K
View more